1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing CancersSolid TumorsActive, not recruitingPhase 12026-08-26NCT03448042